首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
NON-CONTINUOUS IMMUNOASSAY DEVICE AND IMMUNOASSAY METHOD USING THE SAME
摘要
申请公布号
EP1844331(A1)
申请公布日期
2007.10.17
申请号
EP20050726908
申请日期
2005.03.03
申请人
STANDARD DIAGNOSTICS, INC.
发明人
CHO, YOUNG-SHIK;LEE, HYO-KEUN;CHO, BYUNG-KI
分类号
G01N33/543;B01L3/00;C07G11/00;C12M1/34;G01N1/28;G01N33/558
主分类号
G01N33/543
代理机构
代理人
主权项
地址
您可能感兴趣的专利
ROLL PRESS
PACKAGE FOR BULK FOOD PRODUCTS
RECTOLIC, RECTAL ANTI-HEMORRHOID SUPPOSITORY
DEVICE FOR PROTECTION AGAINST RADIOACTIVE CONTAMINATION
THERMO-VACUUM VIBRO-DRIER OF BULK ORGANIC MATERIALS
DISPLACEMENT TRANSDUCER
METHOD FOR DIAGNOSING INCREASED RIGIDITY OF VASCULAR WALL IN CHILDREN AT INCREASED RISK OF EARLY ATHEROSCLEROSIS
INSTALLATION FOR ELECTRIC HEATING OF PREMISES
METHOD FOR DRYING MATERIALS
METHOD FOR REMOVAL OF OIL AND OIL PRODUCTS FROM SOILS
Method for surgical treatment of Dupuytren's disease
METHOD FOR ADAPTIVE CHANGE OF OFDM-SYMBOL CYCLIC PREFIX LENGTH WHILE FORMING OFDM-SYGNALS
diagnostic line of microprism strabismus compensators
Anticuerpo humano aislado o un fragmento de union al antigeno del mismo porque se une o bloquea la actividad biológica de gdf-8 humano maduro de tipo natural; composicion farmacéutica que comprende dicho anticuerpo o el fragmento de unión al antígeno; uso del anticuerpo para tratar una enfermedad o trastorno tratable mediante la inhibición de la actividad de gdf-8.
IMPROVED AMINO ACID SEQUENCES DIRECTED AGAINST IL-6R AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF IL-6R RELATED DISEASES AND DISORDERS
MOUNTING MEANS FOR MOUNTING NATURAL STONE COMPRISING A SPRING AS A SECURING ELEMENT
CHEMICAL COMPOUNDS for treating Hepatitis C virus
THERAPEUTIC APPLICATIONS OF ACTIVATION OF HUMAN ANTIGEN-PRESENTING CELLS THROUGH DECTIN-1
Composicion que comprende el peptido amiloide beta 1-6 acoplado a una particula similar a virus y un auxiliar; vacuna que comprende la composicion; uso de la composicion para tratar o prevenir demencia y enfermedad de alzheimer.
PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK